The global animal biotechnology market deals with developing and applying biotechnological tools and techniques to domestic animals and livestock for advancing reproduction and breeding superior breeds, enhancing production output, and devising therapeutic treatment of animal illnesses. Advancements in assisted reproductive technologies such as IVF, artificial insemination, and sexed semen have boosted milk and egg production from livestock. Genetic engineering enables developing transgenic animals that produce pharmaceuticals. The market is driven by growing meat consumption, rising demand for better animal nutrition and recombinant vaccines and therapeutic proteins from transgenic animals.

The Global Animal Biotechnology Market is estimated to be valued at US$ 25.15 Bn in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the Global Animal Biotechnology Market Demand are Heska Corporation, Indian Immunologicals Ltd., HESTER BIOSCIENCES LIMITED, Zoetis Inc. , Boehringer Ingelheim International GmbH, Biogénesis Bagó, Merck & Co., Inc., Virbac, Elanco, Cadila Pharma, Thermo Fisher Scientific Inc. , Idexx Laboratories, Randox Laboratories Ltd. , Gold Standard Diagnostics. , Bionote USA Inc., Meiji Holdings Co., Ltd., Kemin Industries, Inc., and Pfizer Inc. The key players are investing heavily in R&D to develop enhanced livestock breeding technologies and animal disease diagnostics.

The growing global demand for animal protein is driving the need for higher animal productivity through biotechnological interventions. Livestock farmers are increasingly adopting biotechniques like sexed semen, embryo transfer, and genetic diagnostics for maximizing yields from dairy cows and breeding stock. Advancements in animal biotech are lowering disease prevalence and reducing livestock mortality rates.

Technological advancements like genetic diagnostics, recombinant DNA technology, transgenic animals, cloning are revolutionizing therapeutics and nutrition for farm animals. Genome editing techniques like CRISPR-Cas9 allow precision breeding of disease-resistant and high-yielding livestock breeds. Biotech is enabling development of therapeutics for animal cancers and production of high-value pharmaceuticals using transgenic animal bioreactors.

Market Trends

Growing acceptance of GM livestock: Research entities are developing genetically modified animal breeds with desirable traits like faster growth rates, higher yields, and improved disease resistance which is gaining acceptance globallydespite regulatory hurdles.

Growing popularity of cultured meat: With rising awareness about sustainability, alternatives like cultured meat produced from animal cells without slaughter are gaining traction despite being at a nascent stage currently.

Market Opportunities

Application of genome editing for novel trait development: Genome editing techniques allow introducing desired traits in livestock more precisely and offers opportunity for development of novel breeds.

Commercialization of transgenic pharm animals: Wide commercialization of transgenic animals producing human therapeutic proteins, vaccines can drive huge revenues by lowering production costs compared to traditional methods.

Impact of COVID-19 on the Global Animal Biotechnology Market

The COVID-19 pandemic has severely impacted the growth of the global animal biotechnology market. Strict lockdowns were imposed worldwide which disrupted supply chains and halted production facilities. Veterinary practices and biopharma companies faced challenges due to restrictions on travel and transportation. Decline in disposable incomes also reduced the demand for expensive biopharmaceutical products and genetic services for livestock and companion animals.

However, with the resumption of economic activities, the market is recovering gradually. The long-term need for effective vaccines, diagnostics and therapeutics for animal health remains unchanged. During the pandemic, biotech companies accelerated their R&D efforts to develop therapies against zoonotic diseases like avian influenza and porcine reproductive & respiratory syndrome virus (PRRS). Government support through funding and regulatory relaxations is boosting such innovation.

Companies are enhancing manufacturing capabilities as well as expanding into new geographies to serve growing global demand. Adoption of advanced genetic technologies like gene editing is helping increase productivity and sustainability of animal farms. As veterinarians gain experience with telemedicine, it is expected to complement conventional treatment approaches even in the post-COVID era. Overall, while short-term impact was significant due to the crisis, the market outlook remains positive over the coming years supported by scientific advances.

Geographical Regions with highest market concentration

North America dominates the global animal biotechnology market, accounting for over 35% of the total value in 2024. Significant presence of leading biotech players and high acceptance of advanced genetic solutions by farmers in the US and Canada have driven market growth. Livestock farming is a major economic activity in the region. Europe is another major regional market, supported by robust government funding for animal healthcare R&D in countries like Germany, France and UK.

Fastest growing region

Asia Pacific region is poised to witness the fastest growth over the forecast period. Rising meat consumption and growing milk production in China and India are driving demand for high quality feed, vaccines and semen sexing technologies. Favorable regulatory environment and lower production costs are encouraging pharmaceutical companies to establish manufacturing facilities in countries like Singapore, South Korea and Australia to cater to the Asian markets. Growing adoption of genetic technologies and diagnostics for livestock disease monitoring will further accelerate growth of the animal biotechnology market in the Asia Pacific region.

Get more insights on Global Animal Biotechnology Market